Australian Patent Journal Round-Up 4 April 2013

An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 4 April 2013.

If you wish to oppose the grant of a patent, or if your grant own application has been opposed by third parties, please contact us.

 

Opposition Proceedings

Opposition Lodged

Acceptance of the following patent applications has been opposed:

Application No. Title Applicant(s) Opponent(s)
2007343130 Methods of vaccine administration Pfizer Products Inc. Merial Limited

 

Opposition Withdrawn

Opposition to acceptance of the following applications have been withdrawn.

Application No. Title Applicant(s) Opponent(s)
2003246358 Catheter insertion device B. Braun Melsungen AG Terumo Corporation
2004293118 Neck brace Xceed Holdings Close Corporation Alpinestars SPA
2005201044 Method and medicament for inhibiting the expression of a defined gene Alnylam Pharmaceuticals, Inc. Sirna Therapeutics, Inc.
2011221358 Method For Producing A Synthetic Fibre For Use In An Artificial Grass Sports Field And Such A Synthetic Fibre Ten Cate Thiolon B.V. Tapex Pty Ltd

 

Opposition Dismissed

Opposition proceedings of the following applications have been dismissed.

Application No. Title Applicant(s) Opponent(s)
2004230326 Method for synthesising 5-chloro-1-aryl-4-(4, 5-dicyano-1H-imidazol-2-yl)-3-alkyl-1H-pyrazole derivatives Evultis Merial Ltd

 

Applications Withdrawn

No additional Applications for Opposition have been withdrawn:

 

Extensions of Term of Standard Patents

Applications Filed

No application(s) for Extension of Term under Section 70 have been made.

 

Applications Accepted

No additional application(s) for Extension of Term have been accepted under Section 74.

 

Applications Refused

No additional application(s) for Extension of Term have been refused.

 

Extensions granted

The following application(s) for Extension of Term have been granted under Section 76:

Patent No Title Applicant Approval Date & Goods Expiry Date
2007240156 Peptidomimetic protease inhibitors Vertex Pharmaceuticals Incorporated 06 Mar 2012

For the goods INCIVO telaprevir

31 Aug 2026

 

Surrendered and Revoked Letters Patent

Surrendered Letters Patent

No additional patents have been offered for surrender.

 

Revocation of Letters Patent

No additional patents have been wholly or partially revoked in accordance with Section 137 of the Patents Act.